Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000521643 | SCV000618602 | likely pathogenic | not provided | 2024-11-18 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 37011034, 37842880) |
Labcorp Genetics |
RCV001350739 | SCV001545155 | uncertain significance | Adenylosuccinate lyase deficiency | 2022-02-28 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 296 of the ADSL protein (p.Arg296Trp). This variant is present in population databases (rs536254357, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with ADSL-related conditions. ClinVar contains an entry for this variant (Variation ID: 450065). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genetic Services Laboratory, |
RCV001814999 | SCV002061964 | uncertain significance | not specified | 2017-08-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002527600 | SCV003606748 | uncertain significance | Inborn genetic diseases | 2022-04-08 | criteria provided, single submitter | clinical testing | The c.886C>T (p.R296W) alteration is located in exon 9 (coding exon 9) of the ADSL gene. This alteration results from a C to T substitution at nucleotide position 886, causing the arginine (R) at amino acid position 296 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |